Sakhuja, Rajeev; Mittal, Anupama; Chitkara, Deepak
(Springer, 2020-10-09)
Docetaxel (DTX), an FDA approved chemotherapeutic agent, is used as a first-line treatment for triple-negative breast cancer (TNBC). Its poor aqueous solubility, rapid metabolism, short half-life, and effective targeting ...